NO861907L - Fremgangsmaate for fremstilling av terapeutisk aktive oksotiazolidin-forbindelser. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive oksotiazolidin-forbindelser.

Info

Publication number
NO861907L
NO861907L NO86861907A NO861907A NO861907L NO 861907 L NO861907 L NO 861907L NO 86861907 A NO86861907 A NO 86861907A NO 861907 A NO861907 A NO 861907A NO 861907 L NO861907 L NO 861907L
Authority
NO
Norway
Prior art keywords
alkyl
general formula
compound
salt
alkylcarbamoyl
Prior art date
Application number
NO86861907A
Other languages
English (en)
Norwegian (no)
Inventor
Ikuo Ueda
Yousuke Katsura
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of NO861907L publication Critical patent/NO861907L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Lubricants (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO86861907A 1985-05-14 1986-05-13 Fremgangsmaate for fremstilling av terapeutisk aktive oksotiazolidin-forbindelser. NO861907L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858512163A GB8512163D0 (en) 1985-05-14 1985-05-14 Oxothiazolidine compound

Publications (1)

Publication Number Publication Date
NO861907L true NO861907L (no) 1986-11-17

Family

ID=10579098

Family Applications (1)

Application Number Title Priority Date Filing Date
NO86861907A NO861907L (no) 1985-05-14 1986-05-13 Fremgangsmaate for fremstilling av terapeutisk aktive oksotiazolidin-forbindelser.

Country Status (18)

Country Link
US (1) US4764514A (OSRAM)
EP (1) EP0203743B1 (OSRAM)
JP (1) JPS61267562A (OSRAM)
KR (1) KR860009009A (OSRAM)
AT (1) ATE60762T1 (OSRAM)
AU (1) AU593247B2 (OSRAM)
CA (1) CA1274515A (OSRAM)
DE (1) DE3677413D1 (OSRAM)
DK (1) DK222386A (OSRAM)
ES (2) ES8800185A1 (OSRAM)
FI (1) FI861935A7 (OSRAM)
GB (1) GB8512163D0 (OSRAM)
GR (1) GR861243B (OSRAM)
HU (1) HU195200B (OSRAM)
IL (1) IL78750A (OSRAM)
NO (1) NO861907L (OSRAM)
SU (2) SU1545941A3 (OSRAM)
ZA (1) ZA863285B (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0755937B2 (ja) * 1986-07-29 1995-06-14 日本曹達株式会社 オキサ(チア)ゾリジン誘導体その製造方法及び殺ダニ剤
CA1322199C (en) * 1987-07-15 1993-09-14 Masami Eigyo N-¬(2-oxopyrrolidin-1-yl) acetyl)| piperazine derivatives and drug for senile dementia
EP0316723B1 (en) * 1987-11-20 1992-09-30 Hoechst-Roussel Pharmaceuticals Incorporated 3-[4(1-Substituted-4-piperazinyl)butyl]-4-thiazolidinones a process for their preparation and their use as medicaments
US5066665A (en) * 1990-05-21 1991-11-19 Warner-Lambert Co. Substituted isoxazolidin-3-ones and derivatives thereof acting at muscarinic receptors
DE4404848A1 (de) * 1994-02-16 1995-08-17 Hoechst Ag Substituierte Cyclohexanolester, ihre Verwendung zur Behandlung von Krankheiten und pharmazeutische Präparate
EP0763024B1 (en) 1994-06-03 2002-08-14 JOHN WYETH & BROTHER LIMITED Processes and intermediates for the preparation of piperazine derivatives
CA2200055A1 (en) * 1994-09-16 1996-03-21 Novo Nordisk A/S [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and use
US5596011A (en) * 1995-04-06 1997-01-21 Repine; Karen M. Method for the treatment of macular degeneration
WO1998054164A1 (en) * 1997-05-30 1998-12-03 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, their production and use
US6403595B1 (en) 1998-02-05 2002-06-11 Takeda Chemical Industries, Ltd. Sulfonamide derivatives, processes for producing the same and utilization thereof
CA2440389A1 (en) 2001-03-09 2002-10-03 Ortho-Mcneil Pharmaceutical, Inc. Aminopyrrolidine sulfonamides as serine protease inhibitors
US6710061B2 (en) 2001-03-09 2004-03-23 Ortho-Mcneil Pharamceutical, Inc. Aminopyrrolidine sulfonamides as serine protease inhibitors
US7208497B2 (en) 2001-07-02 2007-04-24 Novo Nordisk A/S Substituted piperazines and diazepanes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3309377A (en) * 1964-10-19 1967-03-14 Sterling Drug Inc 3-[(2-oxazolidinone-3-yl)-alkyl]-4-thiazolidinones and their preparation
IT1194793B (it) * 1981-05-12 1988-09-28 Corvi Camillo Spa Derivati tiazolidinici ad attivita' farmacologica,procedimento per la loro preparazione e composizioni farmaceutiche contenenti detti derivati
DE3315424A1 (de) * 1983-04-28 1984-12-20 Cassella Ag, 6000 Frankfurt Substituierte piperazin-1-yl-essigsaeure-amide, verfahren zu ihrer herstellung und ihre verwendung
FR2552762B1 (fr) * 1983-09-30 1986-07-25 Delalande Sa Nouveaux amides piperaziniques et homopiperaziniques derives de l'acide 3,4-dioxymethylene cinnamique, leur procede de preparation et leur application en therapeutique
GR862081B (en) * 1985-08-09 1986-12-24 Lilly Co Eli Di-t-butylphenol compounds

Also Published As

Publication number Publication date
SU1545941A3 (ru) 1990-02-23
GR861243B (en) 1986-08-28
IL78750A (en) 1990-12-23
DK222386A (da) 1986-11-15
AU593247B2 (en) 1990-02-08
EP0203743B1 (en) 1991-02-06
ATE60762T1 (de) 1991-02-15
ES554901A0 (es) 1987-11-01
FI861935A0 (fi) 1986-05-09
JPH0455431B2 (OSRAM) 1992-09-03
ES8800185A1 (es) 1987-11-01
US4764514A (en) 1988-08-16
DK222386D0 (da) 1986-05-13
ES8802503A1 (es) 1988-07-16
SU1493107A3 (ru) 1989-07-07
IL78750A0 (en) 1986-08-31
EP0203743A1 (en) 1986-12-03
FI861935A7 (fi) 1986-11-15
DE3677413D1 (de) 1991-03-14
CA1274515A (en) 1990-09-25
AU5727686A (en) 1986-11-20
JPS61267562A (ja) 1986-11-27
ES557660A0 (es) 1988-07-16
HU195200B (en) 1988-04-28
GB8512163D0 (en) 1985-06-19
ZA863285B (en) 1986-12-30
HUT41014A (en) 1987-03-30
KR860009009A (ko) 1986-12-19

Similar Documents

Publication Publication Date Title
US11814386B2 (en) Fused pyrrolines which act as ubiquitin-specific protease 30 (USP30) inhibitors
JP2656189B2 (ja) ベンゾイソチアゾールおよびベンゾイソキサゾール−3−カルボキサミド、その製法およびそれよりなる抗精神病剤
ES2242890T3 (es) Agonistas beta 3 de oxindol 3-sustituido.
EP3412660B9 (en) Sulfonamide derivative and pharmaceutical composition containing same
RO113242B1 (ro) Derivati de indol, procedee de preparare, compozitie farmaceutica si metoda de tratament
NO165341B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksamsyrearylderivater.
JP2019526606A (ja) Pad4のヘテロアリール阻害剤
NO177590B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive cykliske aminforbindelser
NO315373B1 (no) Spirosykliske metallprotease-inhibitorer
RU2336273C2 (ru) Амидное производное
TW200902000A (en) Piperidinones useful in the treatment of inflammation
EP0769007A1 (en) 2-ureido-benzamide derivatives
US4764514A (en) Oxothiazolidine compound and composition containing same
DK163581B (da) Kondenserede pyrazol-3-oxo-propannitrilderivater og fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende forbindelserne
EA022776B1 (ru) Арилсульфонамиды для лечения заболеваний цнс
EP0255217B1 (en) Fused imidazoheterocyclic compounds
NO780395L (no) Oksadiazolpyrimidin-derivater.
KR880002013B1 (ko) 1-[3-(6-플루오로-1,2-벤즈이속사졸-3-일)프로필]-4-(치환된)-피페라진 및 이의 제조방법
US4663319A (en) 3-(1,3-dithiol-2-ylidene)-2,4-dioxopyrrolidines, -piperidines, and -hexahydroazepines and use thereof against hepatic diseases
WO2004080965A1 (ja) ニューロペプチドff受容体拮抗剤
NO751055L (OSRAM)
JPH0435470B2 (OSRAM)
NO171727B (no) Fremgangsmaate for fremstilling av okazino(5,6-c)1,2-benzotiazin-6,6-dioksyd
EP0145304B1 (en) Tetrahydro-beta-carboline derivatives and process for the preparation thereof
JPH11130778A (ja) 三環性イミダゾール誘導体、その製造法及び剤